Literature DB >> 10090740

3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo.

W Wu1, Y Chen, A d'Avignon, S L Hazen.   

Abstract

Detection of specific reaction products is a powerful approach for dissecting out pathways that mediate oxidative damage in vivo. Eosinophil peroxidase (EPO), an abundant protein secreted from activated eosinophils, has been implicated in promoting oxidative tissue injury in conditions such as asthma, allergic inflammatory disorders, cancer, and helminthic infections. This unique heme protein amplifies the oxidizing potential of H2O2 by utilizing plasma levels of Br- as a cosubstrate to form potent brominating agents. Brominated products might thus serve as powerful tools for identifying sites of eosinophil-mediated tissue injury in vivo; however, structural identification and characterization of specific brominated products formed during EPO-catalyzed oxidation have not yet been reported. Here we explore the role of EPO and myeloperoxidase (MPO), a related leukocyte protein, in promoting protein oxidative damage through bromination and demonstrate that protein tyrosine residues serve as endogenous traps of reactive brominating species forming stable ring-brominated adducts. Exposure of the amino acid L-tyrosine to EPO, H2O2, and physiological concentrations of halides (100 mM Cl-, </=100 microM Br-) produced two new major products with distinct retention times on reverse phase HPLC. The products were identified as 3-bromotyrosine and 3, 5-dibromotyrosine by electrospray ionization mass spectrometry and multinuclear (1H and 15N) NMR spectroscopy. Formation of the ring-brominated forms of the amino acid occurred readily at neutral pH with the enzymatic system and a variety of reactive brominating species, including HOBr/OBr-, N-bromoamines, and N,N-dibromoamines. Addition of primary amines (e.g., Nalpha-acetyllysine and taurine) to L-tyrosine exposed to either HOBr/OBr- or the EPO-H2O2-Br- system enhanced phenolic ring bromination, suggesting N-bromoamines are preferred brominating intermediates in these reactions. Reduction of N-bromoamines (e.g., Nalpha-acetyl,Nepsilon-bromolysine) by L-tyrosine was shown to result in the loss of reactive halogen with a near stoichiometric increase in the level of tyrosine ring bromination (i.e., carbon-bromine bonds). Although both EPO and MPO could use Br- to halogenate protein tyrosine residues in vitro, only EPO effectively brominated the aromatic amino acid at physiological levels of halides and H2O2. Collectively, these results suggest that 3-bromotyrosine and 3,5-dibromotyrosine are attractive candidates for serving as molecular markers for oxidative damage of proteins by reactive brominating species in vivo. They also suggest that in biological mixtures where amine groups are abundant, the trapping of EPO-generated HOBr/OBr- as N-bromoamines will serve to effectively "funnel" reactive brominating equivalents to stable ring-brominated forms of tyrosine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090740     DOI: 10.1021/bi982401l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

Review 1.  Eosinophil-dependent bromination in the pathogenesis of asthma.

Authors:  J W Heinecke
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

3.  Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site.

Authors:  Adrian G Grozav; Belinda B Willard; Toshiyuki Kozuki; Kenichi Chikamori; Marius A Micluta; Andrei-Jose Petrescu; Michael Kinter; Ram Ganapathi; Mahrukh K Ganapathi
Journal:  Proteomics       Date:  2011-01-31       Impact factor: 3.984

4.  Epigenetics of chronic rhinosinusitis and the role of the eosinophil.

Authors:  Kristin A Seiberling; Christopher A Church; Jason L Herring; Lawrence C Sowers
Journal:  Int Forum Allergy Rhinol       Date:  2011-08-26       Impact factor: 3.858

5.  Analytical validation of fecal 3-bromotyrosine concentrations in healthy dogs and dogs with chronic enteropathy.

Authors:  Panpicha Sattasathuchana; Naris Thengchaisri; Jan S Suchodolski; Jonathan A Lidbury; Jörg M Steiner
Journal:  J Vet Diagn Invest       Date:  2019-02-15       Impact factor: 1.279

Review 6.  New Insights in Oxidant Biology in Asthma.

Authors:  Serpil C Erzurum
Journal:  Ann Am Thorac Soc       Date:  2016-03

7.  Silver oxide nanoparticles alleviate indomethacin-induced gastric injury: a novel antiulcer agent.

Authors:  Neveen A Salem; Mohammed A Wahba; Wael H Eisa; Marwa El-Shamarka; Wagdy Khalil
Journal:  Inflammopharmacology       Date:  2017-12-04       Impact factor: 4.473

8.  Eosinophil Peroxidase Catalyzed Protein Carbamylation Participates in Asthma.

Authors:  Zeneng Wang; Joseph A DiDonato; Jennifer Buffa; Suzy A Comhair; Mark A Aronica; Raed A Dweik; Nancy A Lee; James J Lee; Mary Jane Thomassen; Mani Kavuru; Serpil C Erzurum; Stanley L Hazen
Journal:  J Biol Chem       Date:  2016-09-01       Impact factor: 5.157

9.  Inactivation of thiol-dependent enzymes by hypothiocyanous acid: role of sulfenyl thiocyanate and sulfenic acid intermediates.

Authors:  Tessa J Barrett; David I Pattison; Stephen E Leonard; Kate S Carroll; Michael J Davies; Clare L Hawkins
Journal:  Free Radic Biol Med       Date:  2012-01-08       Impact factor: 7.376

10.  Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition.

Authors:  Semira Galijasevic; Ghassan M Saed; Michael P Diamond; Husam M Abu-Soud
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.